HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection.

Abstract
Insight into molecular and cellular mechanisms of innate immunity is critical to understand viral pathogenesis and immunopathology and might be exploited for therapy. Whereas the molecular mechanisms of the IFN defense are well established, cellular mechanisms of antiviral immunity are only emerging, and their pharmacological triggering remains unknown. COAM is a polysaccharide derivative with antiviral activity but without comprehension about its mechanism of action. The COAM mixture was fractionated, and prophylactic treatment of mice with COAM polymers of high MW resulted in a conversion from 100% lethal mengovirus infection to an overall survival rate of 93% without obvious clinical sequelae. Differential and quantitative analysis of peritoneal leukocytes demonstrated that COAM induced a profound influx of neutrophils. Selective cell depletion experiments pointed toward neutrophils and macrophages as key effector cells in the rescue of mice from lethal mengovirus. COAM was able to induce mRNA and protein expression of the mouse neutrophil chemokine GCP-2. Binding of GCP-2 to COAM was demonstrated in solution and confirmed by SPR technology. Although COAM was not chemotactic for neutrophils, COAM-anchored muGCP-2 retained chemotactic activity for human and mouse neutrophils. In conclusion, this study established that COAM rescued mice from acute and lethal mengovirus infection by recruiting antiviral leukocytes to the site of infection, as proposed through the induction, binding, and concentration of endogenous chemokines. These findings reinforce the role of neutrophils and macrophages as critical cells that can be manipulated toward antiviral defense.
AuthorsSandra Li, Sofie Starckx, Erik Martens, Chris Dillen, Nathalie Lamerant-Fayel, Nele Berghmans, Mieke Gouwy, Melissa van Pel, Hubertine Heremans, Claudine Kieda, Willem E Fibbe, Alfons Billiau, Jo Van Damme, Ghislain Opdenakker
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 88 Issue 5 Pg. 1017-29 (Nov 2010) ISSN: 1938-3673 [Electronic] United States
PMID20709940 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Cytokines
  • Polysaccharides
  • RNA, Messenger
  • Viral Vaccines
  • oxyamylose
  • Amylose
Topics
  • Amylose (analogs & derivatives, pharmacology, therapeutic use)
  • Animals
  • Antiviral Agents (pharmacology, therapeutic use)
  • Cardiovirus Infections (drug therapy, immunology, pathology)
  • Chemotaxis (drug effects, physiology)
  • Cytokines (genetics)
  • Humans
  • Leukocytes (drug effects, physiology)
  • Mengovirus
  • Mice
  • Myeloid Cells (cytology, drug effects, physiology)
  • Polysaccharides (pharmacology)
  • RNA, Messenger (genetics)
  • Viral Vaccines
  • Virus Diseases (immunology, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: